Skip to main content
. 2023 Mar 14;100(11):e1109–e1122. doi: 10.1212/WNL.0000000000206750

Figure 1. Time to Confirmed Disability Progression in Patients With SPMS Treated With AHSCT and Matched Patients Treated With Other Anti-inflammatory DMTs.

Figure 1

Kaplan-Meier Curve for Time to First Confirmed Progression for (A) Propensity Score–Matched Treatment Groups and (B) the Overlap Weighting–Matched Groups. Abbreviations: AHSCT = autologous hematopoietic stem cell transplantation; DMTs = disease-modifying therapies (Beta interferons, azathioprine, Glatiramer Acetate, Mitoxantrone, Fingolimod, Natalizumab, Methotrexate, Teriflunomide, Cyclophosphamide, Dimethyl Fumarate, and Alemtuzumab); EDSS = Expanded Disability Status Scale; HR = hazard ratio; SPMS = secondary progressive multiple sclerosis.